Chansaenroj Jira, Kornsuthisopon Chatvadee, Chansaenroj Ajjima, Samaranayake Lakshman P, Fan Yi, Osathanon Thanaphum
Center of Excellence for Dental Stem Cell Biology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
Center of Excellence for Dental Stem Cell Biology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand; Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
Int Dent J. 2025 Apr;75(2):415-425. doi: 10.1016/j.identj.2024.08.019. Epub 2024 Oct 5.
Human dental pulp stem cells (hDPSCs) have emerged as a promising resource in regenerative medicine due to their unique ability to secrete exosomes containing a diverse array of bioactive molecules, particularly microRNAs (miRNAs). These exosomes appear to be essential for stimulating regenerative mechanisms, especially those associated with stem cell pluripotency and tissue repair. However, several challenges such as cargo specificity and delivery efficiency need to be addressed to maximise the therapeutic potential of hDPSC-derived exosomes and miRNA-based therapies. This narrative review explores hDPSCs' potential in regenerative medicine by examining their role in tissue engineering, secretome composition, exosome function, exosomal miRNA in diverse models, and miRNA profiling. Therefore, it is imperative to sustain ongoing research on miRNA to advance clinical applications in the field of regenerative medicine and dentistry. A comprehensive understanding of the specific miRNA composition within hDPSC-derived exosomes is essential to elucidate their mechanistic roles in diverse disease states and to inform the development of innovative therapeutic strategies. These findings hold significant potential for the development of innovative regenerative therapies and emphasises the importance of establishing a strong connection between translational research discoveries and clinical applications. hDPSC-derived exosomes and miRNA-based therapies play a crucial role in immune modulation, regenerative dentistry, and tissue repair.
人牙髓干细胞(hDPSCs)因其独特的分泌含有多种生物活性分子(特别是微小RNA,即miRNAs)的外泌体的能力,已成为再生医学中一种很有前景的资源。这些外泌体似乎对刺激再生机制至关重要,尤其是那些与干细胞多能性和组织修复相关的机制。然而,为了最大限度地发挥hDPSC来源的外泌体和基于miRNA的疗法的治疗潜力,需要解决诸如货物特异性和递送效率等几个挑战。这篇叙述性综述通过研究hDPSCs在组织工程中的作用、分泌组组成、外泌体功能、不同模型中的外泌体miRNA以及miRNA谱,探讨了hDPSCs在再生医学中的潜力。因此,必须持续开展关于miRNA的研究,以推动再生医学和牙科领域的临床应用。全面了解hDPSC来源的外泌体内特定的miRNA组成,对于阐明它们在不同疾病状态下的作用机制以及为创新治疗策略的开发提供信息至关重要。这些发现对于创新再生疗法的开发具有巨大潜力,并强调了在转化研究发现与临床应用之间建立紧密联系的重要性。hDPSC来源的外泌体和基于miRNA的疗法在免疫调节、再生牙科和组织修复中起着关键作用。